Mammalian prion structures and replication mechanisms are poorly understood. Most synthetic recombinant prion protein (rPrP) amyloids prepared without cofactors are non-infectious or much less infectious than bona fide tissue-derived PrP Sc . This effect has been associated with differences in folding of the aggregates, manifested in part by reduced solvent exclusion and protease-resistance in rPrP amyloids, especially within residues~90-160. Substitution of 4 lysines within residues 101-110 of rPrP (central lysine cluster) with alanines (K 4 A) or asparagines (K 4 N) allows formation of aggregates with extended proteinase K (PK) resistant cores reminiscent of PrP Sc , particularly when seeded with PrP Sc . Here we have compared the infectivity of rPrP aggregates made with K 4 N, K 4 A or wild-type (WT) rPrP, after seeding with scrapie brain homogenate (ScBH) or normal brain homogenate (NBH). None of these preparations caused clinical disease on first passage into rodents. However, the ScBH-seeded fibrils (only) led to a subclinical pathogenesis as indicated by increases in prion seeding activity, neuropathology, and abnormal PrP in the brain. Seeding activities usually accumulated to much higher levels in animals inoculated with ScBHseeded fibrils made with the K 4 N, rather than WT, rPrP molecules. Brain homogenates from subclinical animals induced clinical disease on second passage into "hamsterized" Tg7 mice, with shorter incubation times in animals inoculated with ScBH-seeded K 4 N rPrP fibrils. On second passage from animals inoculated with ScBH-seeded WT fibrils, we detected an additional PK resistant PrP fragment that was similar to that of bona fide PrP Sc . Together these data indicate that both the central lysine cluster and scrapie seeding of rPrP aggregates influence the induction of PrP misfolding, neuropathology and clinical manifestations upon passage in vivo. We confirm that some rPrP aggregates can initiate further aggregation without typical pathogenesis in vivo. We also provide evidence that there is little, if any, biohazard associated with routine RT-QuIC assays. Funding: This work was supported by the Intramural Program of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
. This effect has been associated with differences in folding of the aggregates, manifested in part by reduced solvent exclusion and protease-resistance in rPrP amyloids, especially within residues~90-160. Substitution of 4 lysines within residues 101-110 of rPrP (central lysine cluster) with alanines (K 4 A) or asparagines (K 4 N) allows formation of aggregates with extended proteinase K (PK) resistant cores reminiscent of PrP Sc , particularly when seeded with PrP Sc . Here we have compared the infectivity of rPrP aggregates made with K 4 N, K 4 A or wild-type (WT) rPrP, after seeding with scrapie brain homogenate (ScBH) or normal brain homogenate (NBH). None of these preparations caused clinical disease on first passage into rodents. However, the ScBH-seeded fibrils (only) led to a subclinical pathogenesis as indicated by increases in prion seeding activity, neuropathology, and abnormal PrP in the brain. Seeding activities usually accumulated to much higher levels in animals inoculated with ScBHseeded fibrils made with the K 4 N, rather than WT, rPrP molecules. Brain homogenates from subclinical animals induced clinical disease on second passage into "hamsterized" Tg7 mice, with shorter incubation times in animals inoculated with ScBH-seeded K 4 N rPrP fibrils. On second passage from animals inoculated with ScBH-seeded WT fibrils, we detected an additional PK resistant PrP fragment that was similar to that of bona fide PrP Sc . Together these data indicate that both the central lysine cluster and scrapie seeding of rPrP aggregates influence the induction of PrP misfolding, neuropathology and clinical manifestations upon passage in vivo. We confirm that some rPrP aggregates can initiate further aggregation without typical pathogenesis in vivo. We also provide evidence that there is little, if any, biohazard associated with routine RT-QuIC assays. 's alpha-helical and natively disordered regions into tightly packed assemblies with high beta-sheet content [1, 2] . Conversion of PrP C to PrP Sc is driven by a templated seeded polymerization mechanism in which PrP Sc recruits and catalyzes the refolding of PrP C into growing PrP Sc aggregates [3] [4] [5] [6] [7] .
Since the inception of the hypothesis that an altered form of prion protein is the infectious agent of TSEs, researchers have attempted to produce prion infectivity from PrP molecules alone under chemically defined conditions in vitro. Various in vitro conversion reactions have been developed [4, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . These techniques exploit the self-replicating ability of PrP Sc using natural PrP C or similarly soluble and protease-sensitive PrP (PrP Sen ) substrates from various sources. PrP C substrates for these reactions can be contained in crude brain homogenates [8] or cell lysates [19] , or be purified from various sources [4, 20] . In addition, recombinant PrP Sen (rPrP Sen ) substrates can be expressed and isolated from E. coli [11, 12, 13, 21] . Sonicated protein misfolding cyclic amplification (PMCA) reactions using brain homogenate as a source of PrP C substrate can recapitulate many attributes of the initial PrP Sc seed and generate substantial levels of infectivity [8] . Purified PrP C or rPrP Sen substrates have also been converted by PMCA to infectious forms on their own [14] , but the generation of high-titered rPrP prions that more fully recapitulate the properties of the initial PrP Sc seed has required the presence of cofactors such as RNA and/or phospholipids [21] [22] [23] [24] [25] . Prion-seeded polymerization of rPrP Sen also occurs in shaken reactions in the absence of cofactors or denaturing conditions at near neutral pH, hereafter referred to as real time quaking-induced conversion (RT-QuIC) conditions [16, 17] . Sano et al [26] demonstrated that some strain properties can be conserved transiently in recombinant PrP Res (rPrP Res ) generated under RT-QuIC conditions, but with low infectivity. rPrP Res generated under such conditions has many characteristics of infectious PrP Sc including partial PK-resistance, seeding capabilities, and high beta-sheet secondary structure. However, these conversion products tend to have smaller PK-resistant cores comprised of relatively low molecular weight C-terminal fragments of~8-12 kDa from the region of residues~160-231 [27, 28] . To date there have been no reports of robust infectivity from rPrP Res generated under these, or similar, non-denaturing conditions at neutral pH and without cofactors. The Sano study showed a modest increase in infectivity in a single round of RT-QuIC amplification; however, the infectivity was lost in subsequent serial RT-QuIC reactions [26] . The authors attribute this to rapid growth of off-pathway aggregates that overtake the faithful templating activity of the original prion seeds. Reduced specific infectivity in certain rPrP amyloid preparations has been attributed to incomplete refolding of residues 90-~160, which are more tightly packed and highly protease resistant in more infectious forms of PrP Sc [9, 14, 15, 29, 30] . Tight packing of the 90-~160 region in the absence of cofactors is impeded by a highly conserved cluster of four lysines within residues 101-110 (the central lysine cluster or CLC) [28, [31] [32] [33] . We have hypothesized that this is due to repulsion of their cationic side chains in the absence of ion pairing with suitable anionic residues, cofactors or salts. In any case, wild-type rPrP amyloids formed without cofactors tend to have PK-resistant cores that are restricted to C-terminal residues~160-231 [28, 32] Mutations of the 4 lysines to alanines (K 4 A) or asparagines (K 4 N), which neutralize the lysines within the CLC, allow formation of RT-QuIC products with N-terminally extended PK-resistant cores and with infrared spectra more reminiscent of bona fide PrP Sc in terms of β-sheet amide I vibrations [32, 33] . In this study, we have tested whether these scrapie-seeded RT-QuIC conversion products are infectious for rodents. Furthermore, we tested the influence of CLC mutations on the resulting disease phenotypes. , a dilution that was far beyond the limit of detection of our rodent bioassays and RT-QuIC [16] . PK-treated and untreated RT-QuIC reaction products from each round were analyzed by Western blot using the polyclonal R20 antiserum directed against C-terminal residues 218-231 (Fig 1) . No PrP was detected (Fig 1A, red arrows) in reactions without any rPrP Sen substrate that were seeded initially with 10 −6 scrapie brain and then subjected to serial RT-QuIC rounds. In the reactions containing rPrP Sen substrate we detected predominant~10 and 12 kDa C-terminal PK-resistant bands in the ScBH(WT) RTQ products similar to our previous findings [32] , whereas the NBH(WT) RTQ product showed no PK-resistant rPrP (Fig 1B) Propagation of prion seeding activity in animals inoculated with scrapieseeded RT-QuIC products
Results

PK
The various RT-QuIC conversion products were inoculated intracerebrally into hamsters or Tg7 transgenic mice that over-express hamster PrP C [34] . We will call these first-passage (P1) (Fig 1 and S1 Fig) . However, in the case of NBH(K 4 N) P1 animals, the inoculum contained partially PK-resistant products. Additionally, both the NBH(K 4 N) RTQ product (Fig 1 and S1 Fig) and the brains from the Tg7 NBH(K 4 N) P1 mice collected 2 h after inoculation (n = 2) had RT-QuIC seeding activity, but that activity was not detected in brains collected at later times post-inoculation (S1 Table) . Thus, the NBH(K 4 N) RTQ seeding activity failed to be retained or propagate using endogenous PrP C in vivo. Tg7 mice ( Fig 2C) showed more than a 10-fold increase in seeding activity over the levels measured in a control group 2 h after inoculation. Much stronger evidence for propagation of seeding activity was observed after inoculations with the ScBH(K 4 N) RTQ product, with 3 out of 4 hamsters ( Fig 2B) and all 4 Tg7 mice ( Fig 2D) harvested after !392 days showing increases in seeding activity of~500-100,000 fold. Reinforcing the effects of the CLC mutations, we also saw persistence of seeding activity in all 5 hamsters inoculated with an ScBH(K 4 A) RTQ product and increased levels of seeding activity in 2 out of 5 of those animals (S1A Table) . The observed effects were dose-dependent because the seeding activity was generally weaker in the brains of the animals inoculated with a 1:10 dilution of the ScBH seeded conversion products in inoculation buffer compared with those diluted 1:1 (S1A & S1B Table) . Altogether, these results indicated that both scrapie seeding and the CLC mutations enhanced the in vivo propagation capacities of products generated in vitro in the absence of cofactors or denaturing conditions. Table 1 , and S1A Table) . However, one of the six ScBH(K 4 N) P1 hamsters (A459-2) had a distinct PrP Res banding pattern with three bands at~14, 17, and 22 kDa (Fig 3 and Table 1 ). This banding pattern differed from the~20, 25, and 30 kDa banding pattern of bona fide 263K ScBH PrP Res that was used to initially seed these RT-QuIC reactions (Fig 3) . Furthermore, all four ScBH(K 4 N) P1 Tg7 mice showed the same PK-resistant banding pattern with the same molecular weights of~14, 17, and 22 kDa (Fig 3 and Table 1 Fig) . Deglycosylation with PNGase F showed that the multiple bands containing this PK-resistant core were due to differences in N-linked glycosylation (Fig 4) . This confirmed that rather than being residual unglycosylated rPrP inoculum, the PrP Res being detected in these brains was made endogenously from glycosylated host-derived
Western blot detection of PrP
PrP C .
Histopathological evidence of prion transmission
Blinded histopathological analyses of P1 brains were performed to compare astrogliosis (anti-GFAP staining), spongiosis (hematoxylin and eosin staining), and abnormal PrP deposition (anti-PrP antibody EP1802Y staining). The three ScBH(K 4 N) P1 hamsters with the highest RT-QuIC seeding activities (!~10 7 SD 50 /mg brain; S1A parenchyma near the ventricle but no astrogliosis or spongiosis (S2 Table) . Another (A459-2) had widespread diffuse PrP staining and focal vacuolation in the cerebral cortex (Fig 5) , but no astrogliosis (S2 Table) . A third hamster (A459-1) showed clear PrP
Res deposition, mild spongiform change and moderate astrogliosis in the cerebral cortex and hippocampus ( Table) and minimal pathology in the cortex and hippocampus (Fig 7 and S5 Fig) . Moreover, each of the ScBH (K 4 N) P1 mice with histological lesions were also positive for PrP Res by Western blot and each had high (! 5x10 8 SD 50 /mg brain) RT-QuIC seeding activity (S1 Table) . One ScBH(WT) P1 mouse showed histological signs of prion disease which included small punctate and granular Transmissibility of templated synthetic mutant prion protein aggregates B988-2) and the one ScBH(WT) P1 mouse (B991-1) with strong seeding activity and detectable
PrP
Res were used to inoculate the P2 Tg7 mice (S1C Table) . Regarding the ScBH(K 4 N) P2 mice, three died without overt clinical signs of disease, one at 101 and two at 121 dpi. However, these mice had unused nestlets, which is a common early manifestation of scrapie disease in mice [35] . At 143 dpi, two additional ScBH(K 4 N) P2 mice showed signs of prion disease, including pronounced myoclonus, slight hyperactivity, head tilting, sideways gait, ungroomed coats, and unused nestlets (Table 2 and S1C Table 2 and S1C Table) , similar to the bands seen in the corresponding P1 mice (Fig 3) .
Regarding the ScBH(WT) P2 mice, two were harvested at 143 dpi with possible clinical signs. These mice had RT-QuIC seeding activities of SD 50 s !5.00x10 7 ( Fig 2E and S1C Table) and PrP Res (Table 2 and S1C mice displayed clinical signs and higher prion seeding activities (S1C Table and Fig 2) . Interestingly, immunoblot analysis of brain homogenates of these same mice revealed, in addition to the truncated~14, 17, and 22 kDa bands seen in the ScBH(K 4 N) P2 and 143-dpi ScBH (WT) P2 mice (without PNGase F treatment), higher molecular weight bands reminiscent of the ones found in 263K ScBH-inoculated mice (Fig 8; bracket) . Following PNGase F treatment of this material we detected two predominant bands: the~14 kDa band observed in the ScBH (K 4 N) P2 mice and a~20 kDa band similar to 263K PrP Res (Fig 8; (Table 2 and S1C Table) .
Histopathological comparisons of second passage mice
After second passage, all of the ScBH(K 4 N) P2 and ScBH(WT) P2 mice showed at least two out of three of the neuropathological lesions examined, namely spongiosis, astrogliosis and PrP deposition but with varied intensity and distribution (Figs 6 and 9, S7 Fig, S1C and S2 Tables). The most consistent differences between the ScBH(K 4 N) P2 and ScBH(WT) P2 were i) the level of spongiosis at the relatively early 143 day timepoint (Fig 6) and ii) the more focal lesions in the ScBH(K 4 N) P2 mice compared to the ScBH(WT) P2 mice (S2 Table) serially transmissible prion disease. However, resulting diseases gave distinct clinical, biochemical and histopathological manifestations compared to classical 263K scrapie, indicating that both scrapie templating and mutation of the CLC lysines affect the properties of the synthetic prion strains produced in vitro from rPrP Sen alone without cofactors, denaturants or physiologically implausible pHs.
Discussion
Prion propagation, clearance, and conversion of endogenous PrP C Many, if not most, proteins are capable of assembling into self-propagating amyloid fibrils under certain conditions [36, 37] . A key question is whether such fibrils can be initiated and propagated under physiological conditions. Infectious prion aggregates must be able to survive in the host long enough to initiate formation of new aggregates at a rate that exceeds that of 
Effects of scrapie templating
Here, and in other studies in which prions were made from recombinant PrP in physiologically compatible buffers but in the absence of natural cofactors, initial templating by PrP Sc enhanced the infectivity of the rPrP fibrils [14, 26] . In our case, the ScBH(WT) RTQ Table) . Thus, consistent with conclusions of previous studies [38] [39] [40] , the accumulation of high levels of seeding activity was not necessarily coincident with clinical disease. From a practical perspective, it is notable that we detected increases in seeding activity only when (i) certain ScBH-seeded RT-QuIC products were inoculated into transgenic mice that massively overexpress PrP C or (ii) when unnatural mutant RT-QuIC products [ScBH . Indeed, in our bioassays 2.5 μg of RT-QuIC reaction product was inoculated directly into the brains of hamsters without any apparent pathological effect, making these RT-QuIC products at least 10 6 −10 9 -fold less pathogenic than bona fide 263K PrP Sc (e.g. [1] ) and PrP Sc -seeded products of brain homogenate-based PMCA reactions [41] . Interestingly, Kim et al induced clinical disease on first passage into hamsters inoculated with recombinant hamster 90-231 rPrP
Res generated in sonicated PMCA reactions containing 0.1% SDS and 0.1% Triton X100 [14] . In the present study, the ScBH(WT) RTQ and ScBH (K 4 N) RTQ products were shaken rather than sonicated and contained only 0.002% SDS.
Whether sonication, the much higher detergent content, or the use of N-terminally truncated PrP in the Kim et al study was most responsible for the greater pathogenicity of the rPrP PMCA products is not clear. Notably, SDS has an anionic moiety that might ion-pair with the cationic CLC to facilitate tighter packing in this region. The hydrophobic tail of SDS could also play an important role, analogous to previously observed effects of detergents [30, 42] and lipids [31, 43] on the infectious properties and protease-resistant core of recombinant PrP amyloids.
Effects of CLC mutations
Although scrapie seeding enhanced the pathogenicity of both the ScBH(WT) RTQ and ScBH (K 4 N) RTQ products, the mutant ScBH(K 4 N) RTQ material produced more extensive seed amplification and prion pathogenesis on first passage into both hamsters and Tg7 mice (Tables 1 and 2 and S1A and S1B Table) . On second passage in the mice, both of these infections caused clinical disease and extensive signs of prion pathogenesis, although the appearance of spongiosis and abnormal PrP was slower in the ScBH(WT) RTQ mice (Fig 6) . Given that single preparations of ScBH(WT) RTQ and ScBH(K 4 N) RTQ products were inoculated in the first passage, it remains possible that these differences observed in vivo might have been due to stochastic events during in vitro propagation that were not determined by the WT or K 4 N sequences specifically. However, the biochemical distinctions between the ScBH (WT) RTQ and ScBH(K 4 N) RTQ products shown in Fig 1B were consistently observed in three independent 3-round RT-QuIC reactions. Thus, at present the simplest explanation for the in vivo phenotypes is that they are linked in some way to the observed structural/conformational differences between the ScBH(WT) RTQ and ScBH(K 4 N) RTQ products. Nonetheless, it is difficult to exclude the possibility that the infectious agents produced in the RT-QuIC reactions were low-abundance rPrP species rather than the bulk of the PK-resistant forms that were detected by immunoblotting. Indeed, none of the combined RT-QuIC products that we have generated showed the same predominance of the 17-19-kDa band that is exhibited by PK-and PNGase F-treated 263K PrP Sc (as shown in Fig 4) . Thus, although our biochemical and bioassay data support the idea that the CLC residues and mutations thereof influence misfolding and transmissibility of PrP structures formed in the absence of cofactors, we cannot discriminate clearly between the possibilities that (i) the ScBH(WT) RTQ and ScBH (K 4 N) RTQ products are relatively uniform amyloids that are transmissible and ultimately pathogenic, but much less so than 263K PrP Sc , (ii) the products are mixtures of conformers, only a subset of which are transmissible and/or pathogenic but, again, less so than 263K PrP Sc because we never detected clinical disease on first passage, and (iii) the products are the same as described in ii) but with interference of seed propagation in vivo by non-infectious or non-pathogenic conformers in the preparation.
In any case, our findings raise the question of why the K 4 N and K 4 A mutations promote the formation of more pathogenic scrapie-templated seeds in vitro in the absence of cofactors. One possibility is that neutralization of the cationic lysine sidechains relieves the need for charge compensation by anionic cofactors in vitro in order to achieve a conformation within the~90-160 region [32, 33] that more readily enables the conversion and incorporation of PrP C in vivo. However, these mutations in rPrP clearly did not allow for fully faithful propagation of the 263K PrP Sc strain in RT-QuIC reactions. Thus, the latter must require other molecules or microenvironments that would be available in vivo. A key biochemical feature of the prions in the ScBH(K 4 N) P1 mice was their distinctive~14-kDa PK-resistant core, a feature that was faithfully propagated in ScBH(K 4 N) P2 mice as well. These results suggest that multimers with only this 14-kDa C-terminal core can be infectious. However, the fact that the generation of these multimers was aided by inoculation of the ScBH(K 4 N) RTQ products with Nterminally extended cores provides evidence that structure that is outside the 14-kDa C-terminal core influences the templating activity and transmissibility of synthetic PrP amyloids. Interestingly, the ScBH(WT) P2 mice generated an additional~20 kDa PrP Res species (Fig 8) .
This suggests that the ScBH(WT) RTQ inoculum may have allowed the strain to diverge and generate both forms of PrP Sc , as has been described previously as "deformed templating" [44] . While the~20 kDa species was only seen in the three ScBH(WT) P2 Altogether, the results of this study support the concept that tight folding in the vicinity of the CLC, which is near the N-termini of the PK-resistant and solvent-excluding cores of PrP Sc protomers, is critical in the formation of pathogenic TSE prions. Moreover, the CLC lysines may inhibit the propagation of TSE prions in the absence of charge-compensating cofactors.
Materials and methods
Protein expression and purification
Recombinant hamster PrP C and mutants were purified as previously described [45] . Briefly, BL21(DE3) Rosetta 2 Escherichia coli containing the pET41 vector (EMD, Billerica, MA, USA) with the PrP sequence (Syrian hamster residues 23-231; accession no. K02234, or the PrP sequence including the lysine mutations described in [32] ) were grown in Luria broth medium in the presence of kanamycin and chloramphenicol. Protein expression was induced using the autoinduction system and purified using nickel-nitrilotriacetic acid superflow resin (Qiagen) with an Ä KTA pure chromatography system (GE Healthcare Life Sciences) as previously described [45] . The purified protein was extensively dialyzed into 10 mM sodium phosphate buffer (pH 5.8) and stored at −80˚C. Protein concentration was determined by measuring absorbance at 280 nm.
Inoculum
Scaled-up RT-QuIC reactions were performed as previously described [32] . Reaction mixtures were the same as for RT-QuIC with the exceptions of not including ThT and using the indicated substrates. Reactions were performed at a volume of 1 ml in a 1.5 ml tube in an Eppendorf Thermomixer-R at 700 rpm to generate RT-QuIC products. Reactions were run for 15 h with cycles of 60 s shaking and 60 s of rest throughout the incubation at 42˚C. Tube-based 1000 uL RT-QuIC reactions were seeded with 2μL of a 10 −6 263K prion infected (263K) or normal Syrian Golden hamster (NBH) brain tissue dilutions to initiate templated conversion of the substrate and as a specificity control, respectively. Reactions were limited to an incubation of 15 hours to minimize the incidence of spontaneous conversion in the WT rPrP Sen reactions. Following a 15 hour incubation one microliter of the first round reaction was used to seed a 1 ml second round reaction resulting in a 1:1000 fold dilution of the seed. After a 15 hour incubation we repeated the process by taking one microliter of the second round conversion product to seed a third and final round at an additional 1:1000 dilution of the seed. Three serial passages of the scaled up reactions were performed to achieve a final brain tissue dilution of at least 10
.
Brain homogenates
Brain homogenates were prepared as previously described [45] with the exception of being homogenized in 1X PBS and stored at -80˚C. For RT-QuIC analysis BHs were serially diluted in 0.1% SDS (sodium dodecyl sulfate, Sigma)/N2 (Gibco)/PBS as previously reported [46] .
RT-QuIC
RT-QuIC was performed as previously described [45] . Briefly, for each reaction well 2ul of the indicated brain dilution was added to 98 μL of a reaction mixture resulting in a final concentration of 10 mM phosphate buffer (pH 7.4), 300 mM NaCl, 0.1 mg/mL Ha90-231 rPrP Sen , 10 μM ThT, and 1 mM ethylenediaminetetraacetic acid tetrasodium salt (EDTA). The reaction mix was loaded into each well of a black-walled 96-well plate with a clear bottom and reactions were seeded with 2 μL of the indicated dilution for a final reaction volume of 100 μL containing 0.002% SDS. Plates were sealed and incubated in a BMG FLUOstar plate reader for 30 h with cycles of 60 s shaking and 60 s of rest throughout the incubation at 55˚C. ThT fluorescence measurements (450 ± 10 nm excitation and 480 ± 10 nm emission; bottom read) were taken every 45 min. Fluorescence reactions were judged to be positive or negative prior to 24 h as described previously [47] . Briefly, to compensate for differences between the plate readers, we averaged data from replicate wells and normalized to a percentage of the maximal fluorescence response of the instrument. The obtained values were plotted against the reaction times. Samples were judged to be positive if two or more wells crossed a 10% maximum ThT fluorescence threshold prior to the 24 h cutoff. Spearman-Kärber analysis was used to estimate the seeding dose at which 50% of the replicate wells became positive (SD 50 ) [16, 48] .
Animal inoculations
Prior to inoculation procedures, animals were anesthetized with isoflurane for restraint and pain reduction. Animals were euthanized using carbon dioxide asphyxiation using standard methods recommended by American Veterinary Medical Association guidelines (https:// www.avma.org/KB/Policies/Documants/euthanasia.pdf). Inoculations were performed as previously described [49] . RT-QuIC reaction products were diluted either 1:1 v/v or 1:10 v/v in inoculation buffer (phosphate-buffered balanced saline supplemented with 2% fetal bovine serum) and brain homogenates (10% in PBS) were diluted to the desired final concentration in inoculation buffer. Four-to 6-week-old Tg7 mice, overexpressing Syrian golden hamster (SGH) PrP~5 fold [34] , or SGH were inoculated intracerebrally (i.c.) with 50 μl of the inocula. Animals were observed daily for signs of neurological disease including unused nestlets, poor grooming, kyphosis, ataxia, wasting, delayed response to stimuli, and somnolence and were euthanized on confirmation of progressive neurological disease or at designated time points.
Ethics statement
The animal experimental protocol was reviewed and approved by the Rocky Mountain Laboratories Animal Care and Use Committee (Animal Study Protocol 2014-005 and 2016-039). The Rocky Mountain Laboratories are fully accredited by the American Association for Laboratory Animal Care and this study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
Immunoblot analyses
RT-QuIC reaction products containing 0.1 mg/ml rPrP were treated with 15 μg/ml PK (CAL-BIOCHEM) at 37˚C for 1 h. 20% Brain homogenates in PBS were treated with 50 μg/ml PK at 37˚C for 1 h. Reactions were stopped by diluting in sample buffer containing a final concentration of 4 M urea, 4% SDS, 2% β-mercaptoethanol, 8% glycerol, 0.02% bromophenol blue and 50 mM Tris-HCl; pH 6.8. Sample were then analyzed using Western blot techniques as previously described [32] . Equal volumes of PK-treated reactions were run on 10% Bis-Tris NuPAGE gels (Invitrogen). Proteins were transferred to an Immobilon P membrane (Millipore) using the iBlot Gel Transfer System (Invitrogen). Immunoblotting was carried out using the following α-PrP antibodies: R20 (epitope: residues 218-231), R30 (epitope: 89-103) [50] , 3F4 (Millipore; epitope: 109-112), mAB132 (epitope: 119-127) [51] , and R18 (epitope: 143-156) [50, 52] as previously described [32, 33] .
Pathology and immunohistochemistry
As described previously [49] , SGH or mice were euthanized, brains were removed, and the sagittal half contralateral to the site of inoculation was placed in 50 ml of 3.7% phosphate-buffered formalin for 3 to 5 days before dehydration and embedding in paraffin. New dissection tools were used for each dissection. Antigen retrieval was performed as previously described [49] , followed by staining with rabbit monoclonal antibody (EP1802Y at a 1:6000 dilution) to PrP (Abcam). Astrocyte detection was performed by staining with polyclonal rabbit anti-glial fibrillary acidic protein (anti-GFAP; Dako). Slides were also stained for observation of overall pathology using a standard hematoxylin-eosin (H&E) protocol. All histopathology slides were analyzed by observers blinded to the animal inoculation groups. Histopathology was scored on a scale of 0 to 3 with 0 being no pathology in the entire brain and 3 being severe widespread pathology throughout the brain. Animals with a score above 0 in any of the three lesion types was marked positive for histopathology. 
Supporting information
